Nephrologists Randy Cooper, MD and Umar Waheed, MD, used the Ellipsys Vascular Access System to create a percutaneous arteriovenous fistula at the Tempe, Ariz.-based SKI Vascular Center.
Here are the key details to know:
1. The Ellipsys System is a minimally invasive, single catheter-based system for end-stage renal disease patients.
2. The SKI Vascular Center participated in the U.S. pivotal trial for Ellipsys for FDA approval.
3. The team at SKI Vascular Center have treated over 40 patients with the technology leading up to FDA approval.